Organon & Co., headquartered in Jersey City, develops innovative health solutions in women’s health, biosimilars, and established brands, employing 10,000 people and operating six manufacturing facilities worldwide. The company went public on May 14, 2021, and offers products like Nexplanon and Follistim AQ through various distribution channels.
Kevin Ali bought 34,000 shares of OGN on 5 May at $8.80 per share, worth a total of $299K. They now own 282,731 OGN shares, or a 14% holding increase.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.